MEPOLIZUMAB
UNII 90Z2UF0E52

Substance Identification & Data

This profile provides standardized clinical and technical data for Mepolizumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 90Z2UF0E52.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 196078-29-2 and the RxNorm Concept ID (RxCUI) 1720597. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

90Z2UF0E52

CAS Registry Number

196078-29-2

RxNorm Concept ID

1720597

Detailed Substance Profile

Preferred Name

MEPOLIZUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

90Z2UF0E52

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C157376

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

56603701

Unique identification number in the NCBI database of chemical substances.

INN ID

7876

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

KK-20

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Mepolizumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

MEPOLIZUMAB

Common Names & Synonyms

IMMUNOGLOBULIN G1 (HUMAN-MOUSE MONOCLONAL SB-240563 .GAMMA.1-CHAIN ANTI-HUMAN INTERLEUKIN 5), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL SB-240563 .KAPPA.-CHAIN, DIMER

MEPOLIZUMAB [INN]

MEPOLIZUMAB [JAN]

MEPOLIZUMAB [MI]

MEPOLIZUMAB [PURPLE BOOK CDER]

MEPOLIZUMAB [USAN]

MEPOLIZUMAB [WHO-DD]